Olivia Chu - CEO
A graduate of Columbia University, she brings a background in AI engineering and diagnostic lab operations to bridge the gap between technology and clinical adoption. Olivia is passionate about transforming how labs detect and diagnose cancer by developing tools that are scientifically advanced, practical to deploy, and designed for lasting impact in patient care.
Wenjiang Chu MD, PhD - Founder
20+ years experience as practicing pathologist and lab director at LabCorp, 23andMe, Razor Genomics and NGI. Awarded fellowship at University of Washington for anatomic pathology. Inventor of immunocytochemistry methodology for liquid samples.

